Quick Answer
Ginkgo Bioworks Holdings, Inc. reported Operating Income of -$315.28 million for fiscal year 2025.
Ginkgo Bioworks Holdings, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$315.28M | +43.7% |
| 2024 | -$559.76M | +35.2% |
| 2023 | -$864.41M | +60.9% |
| 2022 | -$2.21B | -20.8% |
| 2021 | -$1.83B | -1234.4% |
| 2020 | -$137.03M | -91.4% |
| 2019 | -$71.60M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$90.02M | -63.1% | -37.3% |
| June 30, 2025 | -$65.54M | +70.6% | +26.3% |
| March 31, 2025 | -$88.97M | +50.0% | -61.2% |
| September 30, 2024 | -$55.20M | +80.7% | +75.2% |
| June 30, 2024 | -$222.94M | -21.1% | -25.2% |
| March 31, 2024 | -$178.00M | +17.5% | +37.8% |
| September 30, 2023 | -$286.39M | +56.3% | -55.5% |
| June 30, 2023 | -$184.15M | +71.6% | +14.6% |
- Ginkgo Bioworks Holdings, Inc. showed an increase of +43.7% in Operating Income compared to the prior fiscal year.
- Over the 2019–2025 period, Ginkgo Bioworks Holdings, Inc.’s operating income has declined by 340.3% (from -$71.60 million to -$315.28 million).
- The most recent figure is from Ginkgo Bioworks Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: